Ohri Manu 4
4 · GT Biopharma, Inc. · Filed Jul 19, 2022
Insider Transaction Report
Form 4
Ohri Manu
Chief Financial Officer
Transactions
- Award
Option to purchase Common Stock
2022-07-15+200,000→ 200,000 totalExercise: $2.48Exp: 2032-07-14→ Common Stock (200,000 underlying) - Award
Common Stock
2022-07-15+100,000→ 100,000 total - Other
Common Stock
2022-07-15−100,000→ 0 total - Other
Common Stock
2022-07-15+100,000→ 100,000 total(indirect: By Anarjay Concepts, Inc.)
Footnotes (2)
- [F1]The reporting person transferred the shares without consideration to Anarjay Concepts, Inc., a corporation wholly-owned by the reporting person.
- [F2]66,666 shares on the date of grant, and 66,667 shares on each February 14, 2023 and 2024.